JXI − Julphar Insulin plant

Julphar Insulin plant is one of the most modern biopharmaceutical manufacturing plants designed for producing recombinant human insulin and insulin analogues crystals (rDNA).

The insulin manufacturing facility is built in accordance with the latest European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regulations, utilising the best available technologies in the market to comply with the latest international quality standards. The plant is among the largest producers of insulin in the world and the only one of its kind in Middle East and North Africa (MENA).

It produces insulin all the way from insulin crystals until final packaged product. The 20,000 square meters extensive facility has the capability to produce 40 million vials of insulin per year. The insulin plant is expected to widen its product offerings and strengthen its market presence in diabetic care. This enables the plant to meet the demands of an increasing rate of diabetes in MENA.

	Annual capacities		1,500 kg recombinant insulin human and insulin analogues crystals (rDNA), 40 million vials of insulin
	Project Type		Biopharmaceutical Plant dedicated to Insulin manufacturing
	Location		Ras Al Khaimah, UAE
	Floor space		20,000 square meters
	Clean rooms		5,000 square meters
	Clean piping		15,000 meters
	Construction		2008
	Completion		2012